Related Experiment Video
Updated: Aug 8, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Prognostic value of myocardial perfusion imaging in symptomatic and asymptomatic patients after percutaneous coronary
Alejandro Solodky1, Abid R Assali, Israel Mats
1Department of Cardiology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. asolodky@clalit.org.il
Insights
Myocardial perfusion imaging (MPI) after percutaneous coronary intervention (PCI) can predict major adverse cardiovascular events (MACE). Ischemia detected by MPI is a stronger predictor than patient symptoms alone.
Area of Science:
- Cardiology
- Diagnostic Imaging
Background:
- Percutaneous coronary intervention (PCI) is a common treatment for coronary artery disease.
- Assessing long-term outcomes after PCI is crucial for patient management.
- Myocardial perfusion imaging (MPI) is a non-invasive technique to evaluate heart blood flow.
Purpose of the Study:
- To determine the predictive value of MPI for major adverse cardiovascular events (MACE) in patients post-PCI.
- To compare the prognostic significance of MPI findings versus clinical symptoms in asymptomatic and symptomatic patients after PCI.
Main Methods:
- Retrospective analysis of patients who underwent MPI after PCI.
- One-year follow-up to track the incidence of MACE.
- Multivariate analysis to identify independent predictors of MACE.
Main Results:
- No significant difference in MACE incidence was observed between symptomatic and asymptomatic patients.
- The presence of myocardial ischemia on MPI was the strongest independent predictor of MACE (OR 5.09).
- MPI-detected ischemia after PCI predicts worse outcomes within one year, irrespective of symptoms.
Conclusions:
- MPI is a valuable tool for risk stratification in patients after PCI.
- Myocardial ischemia identified by MPI is a more potent predictor of adverse cardiovascular events than symptom status.
- MPI findings post-PCI provide critical prognostic information for long-term patient outcomes.
Abstract:
The aim of this study was to evaluate the value of myocardial perfusion imaging (MPI) in predicting major adverse cardiovascular events (MACE) in symptomatic and asymptomatic patients after percutaneous coronary intervention (PCI). We revised retrospectively patients after PCI that underwent MPI and were followed for a year for the presence of MACE. We found no differences in the incidence of MACE between symptomatic and asymptomatic patients. On multivariate analysis, the presence of ischemia by MPI was the most important independent predictor of MACE (OR 5.09, CI 95% 2.15-12.05, p < 0.001). The presence of myocardial ischemia by MPI performed after PCI, and no symptom status, predicts a worse outcome during 1 year of follow-up.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

